Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Arrowhead Research: Fiscal Q1 Earnings Snapshot

Arrowhead Research: Fiscal Q1 Earnings Snapshot

ARWR : 15.36 (+1.92%)
Arrowhead, Sarepta Stocks Rise Despite Price-Target Cuts Post $1B Licensing Deal: Retail Buzz Strong

Piper reduced Sarepta’s price target to $182 from $200, highlighting the partnership’s near-term financial impact.

ARWR : 15.36 (+1.92%)
SRPT : 97.19 (-1.20%)
Arrowhead Pharma Stock Soars Pre-Market On $825M Sarepta Licensing Deal: Retail Activity Hits Year-High

The global licensing deal includes $500 million in cash and $325 million in equity, at a 35% premium upon closing.

ARWR : 15.36 (+1.92%)
SRPT : 97.19 (-1.20%)
IJH : 58.60 (+2.43%)
VTI : 276.99 (+2.14%)
Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Research: Fiscal Q3 Earnings Snapshot

ARWR : 15.36 (+1.92%)
Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Research: Fiscal Q2 Earnings Snapshot

ARWR : 15.36 (+1.92%)
Arrowhead Research: Fiscal Q1 Earnings Snapshot

Arrowhead Research: Fiscal Q1 Earnings Snapshot

ARWR : 15.36 (+1.92%)
Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Research: Fiscal Q3 Earnings Snapshot

ARWR : 15.36 (+1.92%)
Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Research: Fiscal Q2 Earnings Snapshot

ARWR : 15.36 (+1.92%)
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal second quarter ended March 31, 2023. The company is hosting a conference call today, May 2, 2023, at 4:30...

ARWR : 15.36 (+1.92%)
UPS, Packaging Corp. fall, Arrowhead, Tenet rise

Stocks that traded heavily or had substantial price changes Tuesday: UPS, Packaging Corp. fall, Arrowhead, Tenet rise

THC : 122.67 (+2.64%)
JBLU : 5.60 (+1.82%)
CNC : 58.19 (+0.40%)
ARWR : 15.36 (+1.92%)
UPS : 116.76 (+1.33%)
PEP : 148.59 (+0.17%)

Barchart Exclusives

3 High-Yield Dividend Aristocrats Worth Buying To Survive a Recession
These three Dividend Aristocrats care about profitability, predictable dividend growth, and sustainable payout ratios for their income investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar